| abstract |
The present invention provides one or more biomarkers that are associated with fibrosis, e.g. liver fibrosis, and/or diabetes or a prediabetic condition. The invention further provides methods for diagnosing, prognosing and monitoring fibrosis, as well as methods for diagnosing, prognosing and monitoring diabetes, or a prediabetic condition, using said one or more biomarkers, in addition to kits for carrying out such methods. |